Summary
78 / 100 · Bulios Score
What speaks for it
- Out of every 100 USD of revenue, 37 USD is left as net profit.
- It has no debt and holds $93.4M in cash.
- It has raised its dividend 8 years in a row and pays out only 39% of profit.
What to watch
- The share price is above the Bulios Fair Price.
- Revenue grew by only 1.8% a year over the last 3 years.
- Analysts expect revenue to fall by 3.1% this fiscal year.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks expensiveBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 16.9 USD for 1 USD of yearly profit. Over the last five years it was 33.2 USD on average.
Valuation in detailIs it growing?
SlowlyRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue grew by 8.7% a year over 5 years. Over the last 3 years it grew by 1.8% a year. For the next fiscal year analysts expect revenue to fall by 3.1%. Earnings per share grew by 4.9% a year over the last 3 years.
Growth in detailDoes it make money?
Very wellWhere 100 USD of revenue goes
- Cost of sales 25 USD
- Research and development 23 USD
- Sales and administration 17 USD
- Taxes and other -2.1 USD
- Net profit 37 USD
Net profit, industry median (Hardware, Equipment & Parts) 6.8 USD
Out of every 100 USD of revenue, 37 USD is left as net profit.
Profitability in detailIs it financially healthy?
YesIt has no debt.
Financial health in detailDoes it pay a dividend?
Moderate, stretched- Yield
- 2.30%
- Paid out of profit
- 39%
- Raised in a row
- 8 years
You receive $1.95 per share a year. The payout takes a large part of its profit or free cash flow.
Dividends in detailWhat do analysts expect?
Mildly positive- Buy 12
- Hold 6
- Sell 1
Today's price within the analysts' price targets
The average target of $122.6 is 46% above today's price. 63% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
Fiscal year 2025By product
- Material Sales 54%
- Royalty And License Fees 42%
- Contract Research Services 3.5%
By region
- Non-US 49%
- KOREA, REPUBLIC OF 30%
- CHINA 19%
- UNITED STATES 1.9%
- JAPAN 0.2%
- Other 0.1%
Material Sales brings in 54% of revenue. Contract Research Services grew fastest, by 9.1% a year.
Segments in detail